Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 1
2016 1
2017 1
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

7results
Results by year
Filters applied:.Clear all
Page 1
Mycobacterium tuberculosisborderlinerpoBmutations: emerging from the unknown.
Van Deun A, Decroo T, Aung KJM, Hossain MA, Gumusboga M,De Rijk WB, Tahseen S, de Jong BC, Rigouts L. Van Deun A, et al. Among authors:de rijk wb. Eur Respir J. 2021 Sep 2;58(3):2100783. doi: 10.1183/13993003.00783-2021. Print 2021 Sep. Eur Respir J. 2021. PMID:33926970 No abstract available.
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.
Ngabonziza JCS, Decroo T, Migambi P, Habimana YM, Van Deun A, Meehan CJ, Torrea G, Massou F,de Rijk WB, Ushizimpumu B, Niyigena EB, Ivan E, Semahore JM, Mazarati JB, Merle CS, Supply P, Affolabi D, Rigouts L, de Jong BC. Ngabonziza JCS, et al. Among authors:de rijk wb. Lancet Microbe. 2020 Jun;1(2):e74-e83. doi: 10.1016/S2666-5247(20)30007-0. Epub 2020 Jun 8. Lancet Microbe. 2020. PMID:35544156 Free article.
Rifampin drug resistance tests for tuberculosis: challenging the gold standard.
Van Deun A, Aung KJ, Bola V, Lebeke R, Hossain MA,de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC. Van Deun A, et al. Among authors:de rijk wb. J Clin Microbiol. 2013 Aug;51(8):2633-40. doi: 10.1128/JCM.00553-13. Epub 2013 Jun 12. J Clin Microbiol. 2013. PMID:23761144 Free PMC article.
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A,de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”. Ngabonziza JCS, et al. Among authors:de rijk wb. PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017. PLoS One. 2017. PMID:29088294 Free PMC article.
Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
Rigouts L, Coeck N, Gumusboga M,de Rijk WB, Aung KJ, Hossain MA, Fissette K, Rieder HL, Meehan CJ, de Jong BC, Van Deun A. Rigouts L, et al. Among authors:de rijk wb. J Antimicrob Chemother》2016 Feb;71(2):314-23. doi: 10.1093/jac/dkv360. Epub 2015 Nov 24. J Antimicrob Chemother》2016. PMID:26604243 Free PMC article.